- Report
- October 2024
- 181 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
Chlorbenzoxamine is a gastrointestinal drug used to treat symptoms of gastrointestinal disorders such as nausea, vomiting, and abdominal pain. It is a centrally acting antiemetic and antispasmodic agent that works by blocking the action of certain chemicals in the brain that cause nausea and vomiting. It is also used to treat irritable bowel syndrome and other gastrointestinal disorders. Chlorbenzoxamine is available in tablet, capsule, and syrup forms.
Chlorbenzoxamine is a widely used gastrointestinal drug, with a range of applications in the treatment of gastrointestinal disorders. It is generally well tolerated and has few side effects. It is available in generic and brand name formulations, and is often prescribed in combination with other medications.
Some companies in the Chlorbenzoxamine market include Pfizer, Novartis, Merck, GlaxoSmithKline, and Sanofi. Show Less Read more